In Reply
- PMID: 28644322
- DOI: 10.1097/AOG.0000000000002126
In Reply
Comment on
-
Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial.Obstet Gynecol. 2017 Apr;129(4):615-620. doi: 10.1097/AOG.0000000000001928. Obstet Gynecol. 2017. Retraction in: Obstet Gynecol. 2020 Apr;135(4):980. doi: 10.1097/AOG.0000000000003836. PMID: 28277352 Retracted. Clinical Trial.
-
Sildenafil Citrate Therapy for Oligohydramnios: A Randomized Controlled Trial.Obstet Gynecol. 2017 Jul;130(1):219. doi: 10.1097/AOG.0000000000002125. Obstet Gynecol. 2017. PMID: 28644321 No abstract available.
References
-
- Maher MA, Sayyed TM, Elkhouly N. Sildenafil citrate therapy for oligohydramnios: a randomized controlled trial. Obstet Gynecol 2017;129:615–20.
-
- Kiserud T, Acharya G. The fetal circulation. Prenat Diagn 2004;24:1049–59.
-
- Dastjerdi MV, Hosseini S, Bayani L. Sildenafil citrate and uteroplacental perfusion in fetal growth restriction. J Res Med Sci 2012;17:632–6.
-
- Premalatha HL, Raghupathi KMS, Srinivas DNB, Venkatesh, Kanth L. Study of effect of sildenafil citrate in pregnant women with intrauterine growth restriction/oligohydramnios. Int J Reprod Contracept Obstet Gynecol 2016;5:3094–7.
-
- Alanne L, Hoffren J, Haapsamo M, Junno J, Huhta H, Erkinaro T, et al. Effect of sildenafil citrate on fetal central hemodynamics and placental volume blood flow during hypoxemia in chronic sheep model. AJOG 2017;216:S18.
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
